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P U B L I S H E D B Y E L S E V I E R I N C .LettersDeceleration of
Age-Related Aortic
Stiffening in a Population
With High Longevity Rates
The IKARIA StudyIkaria is among the 5 places in the world with the
highest rates of longevity (1). Aortic stiffness,
assessed by aortic pulse wave velocity (PWV), is an
independent predictor of cardiovascular and all-
cause mortality (2).
We evaluated aortic stiffness in 138 healthy in-
habitants of Ikaria Island and investigated whether
there is a differentiation between the measured and
reference PWV. The population was divided into 4 age
groups, each per decade: 40 to 49 years (n ¼ 29); 50 to
59 years (n ¼ 39); 60 to 69 years (n ¼ 31); and$70 years
(n ¼ 39). Aortic stiffness was assessed by measuring
carotid-femoral (aortic) PWV. Participants were non-
diabetic, free from overt cardiovascular disease, and
under no treatment for hypertension or dyslipidemia,
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decade of life, until the very elderly, the measured PWV was
iﬁcantly lower compared to its reference value.Population for PWV (3). We calculated PWV using the
formula PWV ¼ 0.8(xdirect)/Dt (3). Reference values
were calculated by regression equations for PWV ac-
cording to blood pressure (BP) category (optimal BP:
PWV ¼ 0.000  age þ 0.83  103  age2 þ 5.55, normal
BP: PWV ¼ 0.000  age þ 0.99  103  age2 þ 5.69,
high normal BP: PWV ¼ 0.000  age þ 1.05  103 
age2 þ 5.91, grade I hypertension: PWV ¼ 0.000 
age þ 1.18  103  age2 þ 6.17, grade II/III hyperten-
sion: PWV ¼ 0.044  age þ 0.85  103  age2 þ 5.73)
(3). The difference between the reference and mea-
sured PWV in each age group was studied with the
paired Student t test.
The percentage of current smokers was reduced
with advancing age decade (16% vs. 17% vs. 7% vs. 7%,
respectively; p < 0.01). Systolic BP showed a gradual
increase from younger to older inhabitants (from
131.1  11.7 mm Hg to 136.7  14.1 mm Hg to 142.9 
17.1 mm Hg to 152.1  21.8 mm Hg, respectively;
p < 0.01). Interestingly, no difference was observed in
the values of diastolic BP across the age groups (from
81.7 6.5mmHg to 83.9 10.1 mmHg to 80.8 7.7mm
Hg to 81.7  11.6 mm Hg, respectively; p ¼ not signiﬁ-
cant). Regarding the metabolic proﬁle, low-density
lipoprotein cholesterol levels were signiﬁcantly lower
in the elderly group 4 compared with group 1, but
no signiﬁcant difference was observed between all
other group comparisons (from 145.9  35.1 mg/dl to
136.9  35.4 mg/dl to 133.9  42.5 mg/dl to 120.6 
35.5 mg/dl, respectively). Importantly, values of high-
density lipoprotein cholesterol were similar among all
groups (from 46.6  10.4 mg/dl to 47.1  9.7 mg/dl to
48.68.8mg/dl to 44.6 11.3 mg/dl; p¼NS), implying
a constant favorable high-density lipoprotein choles-
terol proﬁle across all age groups. Plasma glucose
levels did not signiﬁcantly change among groups.
PWV showed a gradual increase from the fourth
decade of life to the elderly (p ¼ 0.05 for the compari-
son between groups 1 and 2; p < 0.01 for the compari-
son between all other groups). No difference between
the measured and reference values was observed in
subjects between 40 and 49 years old (7.98  0.96 m/s
vs. 7.92  0.69 m/s, respectively; p ¼ NS), but after the
ﬁfth decade of life, measured PWV was consistently
and signiﬁcantly lower than the reference values in all
age groups (group 2: 8.71 1.22 m/s vs. 9.220.80m/s;
p < 0.01; group 3: 9.87  1.17 m/s vs. 10.78  0.92 m/s;
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1843p < 0.001; and group 4: 11.53  2.22 m/s vs.
13.17  1.54 m/s; p < 0.001) (Figure 1). In multivariate
regression analysis, PWV was independently related
to age group (b ¼ 0.61; p < 0.001), mean BP (b ¼ 0.29;
p ¼ 0.001), heart rate (b ¼ 0.23; p ¼ 0.006), and
creatinine (b ¼ 0.19; p ¼ 0.01); (R2 of the model: 0.59).
In the present study, we assessed aortic stiffness in
a population with high rates of longevity. Aortic stiff-
ness increases gradually with age; however, at >50
years of age, aortic stiffening seems to be decelerated
because the measured PWV was signiﬁcantly lower
than reference values. This ﬁnding may be attributed
to either a favorable hemodynamic pattern (progres-
sive increase in systolic BP with age, but stable dia-
stolic BP at older ages—an excessive decrease of
diastolic BP hampers coronary ﬂow) or to beneﬁcial
genetic and metabolic backgrounds that are impli-
cated in the process of both longevity and aortic
stiffness. The favorable lipid proﬁle and the relatively
low percentage of smokers among the elderly may
have contributed to the results (4). Moreover, previous
results from the IKARIA study showed a favorable ef-
fect of physical activity on endothelial function, which
may be related to attenuated aortic stiffening (1). He-
reditary aspects of aortic elasticity may also play a role
given the evidence that paternal longevity is associ-
ated with decreased PWV in offspring (5).
The cross-sectional nature of our study does not
allow for conclusions regarding causality, and selec-
tion bias may have interfered. Whether this privilege
of aortic mechanics can also be extended to the
younger generations living in the particular island is a
hypothesis that needs further investigation. Finally,
aortic imaging modalities that provide structural in-
formation could have enhanced our results.
Whether aortic stiffness retains its established pre-
dictive value with increasing age is an intriguing issue,
with most studies attesting to an incremental predic-
tive ability even at older ages. Given the adverse
prognostic impact of aortic stiffening on cardiovascu-
lar and total mortality, the present ﬁndings may imply
a possible link between longevity and aortic stiffness.*Panagiota Pietri, MD
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2702–7.Clinical Relevance of
Exaggerated Exercise
Blood PressureExercise stress testing is routinely used to assess
cardiovascular risk, and measurement of blood pres-
sure (BP) during the test is a standard component of
patient monitoring (1). Irrespective of whether BP is
considered normal at rest (in-clinic BP <140/90
mm Hg), some individuals may experience abnormal
(hypotensive or hypertensive) BP responses during
exercise testing. Our recent meta-analyses demon-
strated that abnormal BP responses carry signiﬁcant
risk for future cardiovascular events and mortality,
independent of resting BP and other cardiovascular
risk factors (2,3). Although exercise hypotension is a
sign of signiﬁcant cardiovascular pathology, it is
possible that some of the cardiovascular risk associ-
ated with exercise hypertension (exaggerated exer-
cise blood pressure [EEBP]) relates to underlying
(masked) hypertension (4) gone unnoticed with clinic
BP screening, or to future development of overt hy-
pertension detectable with in-clinic BP screening. A
pooled summary of studies assessing the relationship
between EEBP and incident hypertension has never
been undertaken, and is an important step with
respect to determining whether EEBP has utility
for early identiﬁcation of people at heightened car-
diovascular risk. Therefore, we sought to conduct a
systematic review and meta-analysis to determine
